Bank Of New York Mellon Corp Cns Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.26 - $0.43 $8,149 - $13,477	-31,344 Reduced 13.34%	203,548 $57,000
Q1 2022 May 11, 2022	BUY	$0.26 - $1.05 $53,334 - $215,390	205,134 Added 689.34%	234,892 $80,000
Q3 2021 Nov 12, 2021	SELL	$1.4 - $1.98 $19,461 - $27,523	-13,901 Reduced 31.84%	29,758 $44,000
Q1 2021 May 13, 2021	BUY	$1.72 - $4.18 $75,093 - $182,494	43,659 New	43,659 $104,000

100

Ticker CNSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,032,500
Market Cap $4.4M
Description
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme....

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.